Sanders Morris Harris’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,020
| Closed | -$289K | – | 211 |
|
|
2025
Q1 | $289K | Hold |
4,020
| – | – | 0.04% | 210 |
|
|
2024
Q4 | $298K | Hold |
4,020
| – | – | 0.04% | 221 |
|
|
2024
Q3 | $265K | Hold |
4,020
| – | – | 0.04% | 230 |
|
|
2024
Q2 | $371K | Hold |
4,020
| – | – | 0.06% | 191 |
|
|
2024
Q1 | $384K | Hold |
4,020
| – | – | 0.07% | 187 |
|
|
2023
Q4 | $303K | Hold |
4,020
| – | – | 0.15% | 144 |
|
|
2023
Q3 | $275K | Sell |
4,020
-600
| -13% | -$41.1K | 0.06% | 202 |
|
|
2023
Q2 | $424K | Buy |
+4,620
| New | +$424K | 0.09% | 161 |
|
|
2023
Q1 | – | Sell |
-4,620
| Closed | -$345K | – | 183 |
|
|
2022
Q4 | $345K | Hold |
4,620
| – | – | 0.13% | 140 |
|
|
2022
Q3 | $395K | Hold |
4,620
| – | – | 0.1% | 163 |
|
|
2022
Q2 | $449K | Hold |
4,620
| – | – | 0.1% | 164 |
|
|
2022
Q1 | $544K | Hold |
4,620
| – | – | 0.11% | 152 |
|
|
2021
Q4 | $592K | Hold |
4,620
| – | – | 0.1% | 153 |
|
|
2021
Q3 | $515K | Hold |
4,620
| – | – | 0.09% | 161 |
|
|
2021
Q2 | $490K | Hold |
4,620
| – | – | 0.1% | 174 |
|
|
2021
Q1 | $388K | Hold |
4,620
| – | – | 0.08% | 193 |
|
|
2020
Q4 | $414K | Hold |
4,620
| – | – | 0.09% | 181 |
|
|
2020
Q3 | $384K | Buy |
+4,620
| New | +$384K | 0.1% | 177 |
|
|
2020
Q2 | – | Sell |
-4,020
| Closed | -$216K | – | 145 |
|
|
2020
Q1 | $216K | Hold |
4,020
| – | – | 0.21% | 103 |
|
|
2019
Q4 | $303K | Hold |
4,020
| – | – | 0.07% | 220 |
|
|
2019
Q3 | $288K | Buy |
+4,020
| New | +$288K | 0.07% | 210 |
|
|
2016
Q4 | – | Sell |
-5,100
| Closed | -$205K | – | 137 |
|
|
2016
Q3 | $205K | Buy |
+5,100
| New | +$205K | 0.06% | 138 |
|